Denali Advisors LLC Sells 81 Shares of Intuitive Surgical, Inc. $ISRG

Denali Advisors LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,660 shares of the medical equipment provider’s stock after selling 81 shares during the quarter. Denali Advisors LLC’s holdings in Intuitive Surgical were worth $1,989,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Norway Savings Bank increased its stake in Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after acquiring an additional 910 shares during the last quarter. IronOak Wealth LLC. bought a new stake in Intuitive Surgical during the second quarter worth approximately $1,099,000. Trust Co. of Oklahoma bought a new stake in Intuitive Surgical during the second quarter worth approximately $363,000. Neville Rodie & Shaw Inc. increased its stake in Intuitive Surgical by 11.9% during the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after acquiring an additional 1,110 shares during the last quarter. Finally, Sax Wealth Advisors LLC increased its stake in Intuitive Surgical by 218.1% during the second quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock worth $1,334,000 after acquiring an additional 1,684 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $462.74 on Wednesday. The firm has a market capitalization of $165.88 billion, a price-to-earnings ratio of 64.54, a PEG ratio of 4.81 and a beta of 1.61. The stock has a 50 day moving average price of $454.39 and a 200 day moving average price of $495.58. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.84 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. The Goldman Sachs Group reduced their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday, October 1st. Wells Fargo & Company boosted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research report on Wednesday, July 23rd. Mizuho dropped their target price on Intuitive Surgical from $570.00 to $520.00 and set a “neutral” rating for the company in a research report on Tuesday, October 14th. UBS Group set a $529.00 target price on Intuitive Surgical in a research report on Monday, October 13th. Finally, Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday. Fifteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $585.05.

Insider Activity at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.